Success Metrics

Clinical Success Rate
94.5%

Based on 224 completed trials

Completion Rate
95%(224/237)
Active Trials
41(12%)
Results Posted
25%(55 trials)
Terminated
13(4%)

Phase Distribution

Ph phase_2
25
8%
Ph phase_4
17
5%
Ph not_applicable
253
77%
Ph phase_3
9
3%
Ph early_phase_1
1
0%
Ph phase_1
17
5%

Phase Distribution

18

Early Stage

25

Mid Stage

26

Late Stage

Phase Distribution322 total trials
Early Phase 1First-in-human
1(0.3%)
Phase 1Safety & dosage
17(5.3%)
Phase 2Efficacy & side effects
25(7.8%)
Phase 3Large-scale testing
9(2.8%)
Phase 4Post-market surveillance
17(5.3%)
N/ANon-phased studies
253(78.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

224 of 240 finished

Non-Completion Rate

6.7%

16 ended early

Currently Active

41

trials recruiting

Total Trials

329

all time

Status Distribution
Active(46)
Completed(224)
Terminated(16)
Other(43)

Detailed Status

Completed224
unknown43
Recruiting34
Terminated13
Active, not recruiting7
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
329
Active
41
Success Rate
94.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.3%)
Phase 117 (5.3%)
Phase 225 (7.8%)
Phase 39 (2.8%)
Phase 417 (5.3%)
N/A253 (78.6%)

Trials by Status

not_yet_recruiting41%
terminated134%
completed22468%
active_not_recruiting72%
recruiting3410%
enrolling_by_invitation10%
withdrawn31%
unknown4313%

Recent Activity

Clinical Trials (329)

Showing 20 of 329 trialsScroll for more
NCT06786429Phase 4

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Not Yet Recruiting
NCT00018057Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Recruiting
NCT05283200Not Applicable

Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy

Active Not Recruiting
NCT03906435Not Applicable

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

Recruiting
NCT03531450Not Applicable

Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients

Completed
NCT06044649Not Applicable

Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

Active Not Recruiting
NCT06484400Not Applicable

Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms

Completed
NCT02066792Early Phase 1

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

Completed
NCT02482805Not Applicable

Hormones and Social Anxiety Disorder Treatment

Completed
NCT06511518Not Applicable

Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment

Recruiting
NCT06574035Not Applicable

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

Recruiting
NCT07503951Not Applicable

Cognitive Behavior Therapy in Psychiatric Inpatient Care

Recruiting
NCT06956417Not Applicable

REhabilitation of MEMory Symptoms After BRain Concussion

Recruiting
NCT07609953Not Applicable

Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia

Completed
NCT05215353Phase 4

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Recruiting
NCT04338178Not Applicable

Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.

Terminated
NCT06245096Not Applicable

Evaluating Process of Change in Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for Depression

Completed
NCT05227612Phase 1

Psilocybin-assisted CBT for Depression

Completed
NCT07588724Not Applicable

Effectiveness of Cognitive Behavioral Therapy on Psychological Distress and Problem-Solving Skills in Women With Vaginismus

Completed
NCT07119710Not Applicable

Telehealth to Improve Quality of Life in Persons Living in Rural Texas

Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
329